20112-81-6

Basic information

• Product Name: Pyrimidine, 1,4,5,6-tetrahydro-2-(methylthio)- (7CI, 8CI, 9CI)
• Synonyms: Pyrimidine, 1,4,5,6-tetrahydro-2-(methylthio)- (7CI, 8CI, 9CI);2-(METHYLSULFANYL)-1,4,5,6-TETRAHYDROPYRIMIDINE;2-(methylthio)-1,4,5,6-tetrahydropyrimidine
• CAS NO: 20112-81-6
• Molecular Formula: C₅H₁₀N₂S
• Molecular Weight: 130.2113
• Product Categories: THIOL
• Mol File: 20112-81-6.mol
• Article Data: 12

Chemical Properties

• Melting Point: 153-155 °C
• Boiling Point: 208.0±23.0 °C(Predicted)
• Appearance: /
• Density: 1.21±0.1 g/cm3(Predicted)
• PKA: 10.28±0.20(Predicted)
• CAS DataBase Reference: Pyrimidine, 1,4,5,6-tetrahydro-2-(methylthio)- (7CI, 8CI, 9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrimidine, 1,4,5,6-tetrahydro-2-(methylthio)- (7CI, 8CI, 9CI)(20112-81-6)
• EPA Substance Registry System: Pyrimidine, 1,4,5,6-tetrahydro-2-(methylthio)- (7CI, 8CI, 9CI)(20112-81-6)

Safety Data

• Hazardous Substances Data: 20112-81-6(Hazardous Substances Data)

Upstream product

• 2055-46-1 2-mercapto-3,4,5,6-tetrahydropyrimidine 
• 74-88-4 methyl iodide 
• 2055-46-1 3,4,5,6-tetrahydropyrimidine-2-thione 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 55110-65-1 1,4,5,6-tetrahydro-2-pyrimidinylhydrazine 
• 19801-37-7 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido<2,1-b>quinazoline 
• 101989-57-5 1-benzoyl-6-methylthio-7-phenoxyacetamido-1-azacepham 
• 101989-54-2 7-carbethoxyacetonylamino-1-benzoyl-6-methylthio-1-azacepham 
• 101989-56-4 7-amino-1-benzoyl-6-methylthio-1-azacepham 
• 91530-83-5 (6S,7S)-7-(2,4-Dichloro-phenoxy)-5-[2-(2,4-dichloro-phenoxy)-acetyl]-6-methylsulfanyl-1,5-diaza-bicyclo[4.2.0]octan-8-one 
• 91530-82-4 (6R,7S)-7-(2,4-Dichloro-phenoxy)-6-methylsulfanyl-8-oxo-1,5-diaza-bicyclo[4.2.0]octane-5-carboxylic acid ethyl ester 
• 54679-37-7 (6S,7S)-6-Methylsulfanyl-7-phenoxy-5-(2-phenoxy-acetyl)-1,5-diaza-bicyclo[4.2.0]octan-8-one 
• 91530-93-7 1-benzyloxycarbonyl-6-methylthio-7-phenoxy-1-azacepham 
• 91530-84-6 1-benzoyl-6-methylthio-7-phenoxy-1-azacepham 
• 54679-28-6 (6R,7S)-6-Methylsulfanyl-8-oxo-7-phenoxy-1,5-diaza-bicyclo[4.2.0]octane-5-carboxylic acid ethyl ester 
• 91530-85-7 (6S,7S)-5-Acetyl-6-methylsulfanyl-7-phenoxy-1,5-diaza-bicyclo[4.2.0]octan-8-one 
• 956360-69-3 1-[5-(3-Chloro-phenyl)-isoxazol-3-ylmethyl]-2-methylsulfanyl-1,4,5,6-tetrahydro-pyrimidine 
• 1852-17-1 3,4,5,6-tetrahydropyrimidin-2(1H)-one 

Relevant articles and documents

Synthesis, Antileishmanial Activity and In Silico Studies of Aminoguanidine Hydrazones (AGH) and Thiosemicarbazones (TSC) Against Leishmania chagasi Amastigotes

Background: Leishmaniasis is a worldwide health problem, highly endemic in developing countries. Among the four main clinical forms of the disease, visceral leishmaniasis is the most se-vere, fatal in 95% of cases. The undesired side-effects from first-li

USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS

Use of caseinolytic protease P (ClpP) function and/or concentration as a biomarker for predicting the response of a neoplastic disease, preferably cancer or another disease where enhancing ClpP activity may provide a therapeutic benefit, to a compound of Formula I. In other aspects it relates to methods and kits, as well as methods of treatment involving the use of the biomarker.

MGluR5 modulators V

The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.